It seems that overexpression of BCL-1 and BCL-2 associated with t(11;14) inhibits apoptosis and BCL-2 sequestration by venetoclax allows plasma cells to undergo apoptosis and more effectively induces deep and long-lasting remissions in “low malignancy” plasma cell dyscrasias like AL. This evidence concerns the gene BCL2 and plasma cell neoplasm.